Clover Health (CLOV) VP Joseph Oldakowski Sells 3,170 Shares

What Happened Joseph Frank Oldakowski, Vice President of Finance and Controller at Clover Health (CLOV), reported a sale of 3,170 shares of Class A common stock on 2026-09-16 at $4.64 per share, generating proceeds of $14,709. This was a sale (S) required to satisfy tax withholding related to the vesting of restricted stock units (RSUs), not a discretionary trade.

Key Details

• Transaction date and price: 2026-09-16, 3,170 shares sold at $4.64/share (total $14,709).
• Transaction type: Sale (S); sale was a "sell-to-cover" to satisfy tax withholding (see footnote).
• Footnote: The shares sold were required to cover tax withholding on 6.25% of RSUs granted 6/16/2025; remaining RSUs vest in equal quarterly 6.25% installments through 6/16/2029, subject to continued service.
• Shares owned after transaction: Not disclosed in this Form 4.
• Filing timeliness: Form 4 filed 2026-09-17 (within the usual two-business-day window).

Context Sell-to-cover transactions are routine administrative sales to satisfy tax obligations when RSUs vest and generally do not indicate the insider’s view on the company’s stock. The filing clarifies these sales were mandated by the issuer’s equity plan election and were not discretionary trades by the reporting person.